The role of cannabinoids in eating disorders

Medicine and Dentistry

• Cannabinoid 100%
• Eating Disorder 100%
• Treatment of Eating Disorders 28%
• Ingestion of Food 28%
• Serotonin 28%
• Norepinephrine Reuptake Inhibitor 14%
• Neuropeptide Y 14%
• Ingestion 14%
• Gamma-Aminobutyric Acid 14%
• Tricyclic Antidepressant 14%
• Anorexia Nervosa 14%
• Eating Behavior 14%
• Prostaglandin 14%
• Opioid Peptide 14%
• Antidepressant 14%
• Mood Stabilizer 14%
• Selective Serotonin Reuptake Inhibitor 14%
• Antipsychotic Drug 14%
• Brain Areas 14%
• Noradrenalin 14%
• Night Eating Syndrome 14%
• Food Intake 14%
• Bulimia 14%

Neuroscience

• Eating Disorder 100%
• Cannabinoid 100%
• Treatment of Eating Disorders 28%
• Anorexia Nervosa 14%
• Neuropeptide Y 14%
• Norepinephrine Reuptake Inhibitor 14%
• Prostaglandin 14%
• Norepinephrine 14%
• Opioid Peptide 14%
• Serotonin Reuptake Inhibitor 14%
• Gamma-Aminobutyric Acid 14%
• Eating Behavior 14%
• Mood Stabilizer 14%
• Antipsychotic 14%
• Binge Eating Disorder 14%
• Bulimia Nervosa 14%
• Brain Areas 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Eating Disorder 100%
• Prostaglandin 11%
• Serotonin Reuptake Inhibitor 11%
• Noradrenalin 11%
• Mood Stabilizer 11%
• Bulimia 11%
• Antipsychotic Drug 11%
• Neuropeptide Y 11%
• Norepinephrine Reuptake Inhibitor 11%
• 4 Aminobutyric Acid 11%
• Anorexia Nervosa 11%
• Binge Eating Disorder 11%